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Q2Interactions of rutin with the oxidovanadium(IV)
cation. Anticancer improvement effects of
glycosylated flavonoids†
Helen Goitia,a Patricia Quispe,a Luciana G. Naso,a Valeria R. Martı́nez,a Marilin Rey,b
Alberto C. Rizzi,b Evelina G. Ferrer a and Patricia A. M. Williams *a
This work reports the biological evaluation of the new complex Na2[VO(rut)(OH)2]5H2O (rut = rutin, a
glycosylated flavonoid). The complex was different in its coordination mode (catechol-like) from those
previously reported, [VO(rutin)(H2O)2]2(SO4)4H2O and [VO(rut)2]4H2O (acetylacetonate-like
coordination). Due to the coordination mode, the complex only improved the antioxidant activity of the
ligand against superoxide and hydroxyl radicals. The results show that while both 100 mM rutin and
V(IV)O did not exhibit cytotoxic activity on A549 cells, the complex selectively improved the anticancer
effect (IC50 = 95 mM), cellular reactive oxygen species (ROS) generation and depletion of the non-
enzymatic antioxidant glutathione (GSH), producing oxidized glutathione (GSSG), and it did not affect
the viability of the normal embryonic lung cell line (MRC-5) (up to 100 mM). All these data, and given the
reversion of the cell killing effect of the complex upon treatment with the antioxidant agent N-acetyl-L-
cysteine (NAC), suggested an oxidative stress mechanism. Rutin and VOrut can spontaneously bind
bovine serum albumin (BSA) and they can be stored and transported by the protein.
1. Introduction
Polyphenolic flavonoids are a group of natural substances with
antioxidant activity. The glycoside flavonoid rutin (quercetin-3-
O-rutinose, disaccharides: rhamnose and glucose, Fig. 1) is
usually found in black tea, buckwheat and apple peel. Rutin
has been investigated for its antioxidant, antiinflammatory,
anti-tumor, anti-thrombotic, cardio-protective and antibacterial
activity1,2 and was used as a multifunctional agent to decrease
cell adhesion and migration of human lung and colon cancer
cells and to inhibit cell proliferation. All these results showed
that rutin can be one of the major effective ingredients in the
therapeutic treatment of cancer diseases.3 In addition, due to
the different coordination sites in its chemical structure it can
form coordination complexes with transition metal ions (Cu(II),
Fe(II), Al(III), and Zn(II))4,5 and it has been demonstrated that its
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system). (B) Peroxyl radicals generated by the thermal decomposition of AAPH (2,2-azobis(2-amidinopropane)dihydrochloride); the lag phase is the delay of the
consumption of the spectrometric probe, pyranine, calculated as the time due to the consumption of peroxyl radicals by the added compounds, before the
consumption of pyranine started. (C) Extent of deoxyribose degradation by hydroxyl radicals, measured with the thiobarbituric acid method. (D) Reduction of the
concentration of 1,1-diphenyl-2-picrylhydrazyl radicals. The values are expressed as the mean  the standard error of at least three independent experiments. Fig. S6.
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Furthermore, the anticancer activity of metal complexes is
considered as one of their most important potential applica-
tions. After the discovery of cisplatin and carboplatin as
potential chemotherapeutic agents, the interest in developing
non-platinum metal complexes as a drug has stimulated
increased research. Vanadium coordination compounds exhib-
ited different biological effects like diabetes and lipid profile
regulation, cancer regulation and apoptosis.6 Hence, these
kinds of complexes are suitable candidates for cancer
treatment.
In previous papers we have demonstrated a structure–activ-
ity relationship on the antioxidant power of V(IV)O–flavonoid
complexes. A better improvement of the antioxidant behavior of
flavonoids upon complexation was found for those complexes
in which the coordination sites are the carbonyl and one
deprotonated OH group forming six or five membered rings,
with maltol-type or acetylacetonate-type structures, respectively.
In these systems the phenoxyl radicals generated by electron
donation to free radicals were stabilized by the p electronic
resonance between the VQO cation and rings A and C of the
flavonoids. On the other hand, in the glycosylated derivatives
the CQO group did not coordinate to the metal center and a
lower improvement of the antioxidant properties of the flavo-
noids was determined.7
Conversely, in the A549 human cancer cell line, a better
improvement of the anticancer effect and cellular ROS genera-
tion upon complexation was found for the oxidovanadium(IV)
complexes with glycosylated flavonoids.8,9 To confirm that this
effect is due to the presence of glyosidic bonds in the flavonoid
structure we have selected herein the V(IV)O complex with the
glycosylated flavonoid rutin. We report the synthesis and
characterization of the oxidovanadium(IV)–rutin complex
Na2[VO(rut)(OH)2]5H2O and the evaluation of its antioxidant
and biological properties in lung human cancer cells. Two
complexes of rutin with the oxidovanadium(IV) (V(IV)O) cation
have recently been prepared and they displayed
acetylacetonate-type coordination (O(4), O(5)).10,11 Attempts to
obtain the same complexes gave a solid complex in which rutin
chelates to the metal center through a catechol-like environ-
ment (O(30), O(40)). A similar rutin/V(IV)O complex with a
catechol-type environment has been previously prepared in
the solution phase and characterized by EPR spectroscopy.12
The new complex was studied using different spectroscopic
techniques (FTIR, UV-vis, and EPR), TGA-DTA and elemental
analyses. The flavonoid rutin displayed higher antioxidant
activities than the complex against DPPH and peroxyl radicals
and lower scavenging power against hydroxyl and superoxide
radicals. The complex exhibited a better cytotoxic effect than
rutin (tested in the human lung A549 cancer cell line) via an
oxidative stress mechanism, without affecting the normal
embryonic lung cell line (MRC-5). The ligand and complex
could be carried in the bloodstream by albumin.
2. Experimental section
2.1. Materials
All chemicals were analytical grade and used without further
purification. Rutin (Nanjing Zelang Medical Technology Co.,
Ltd) and oxidovanadium(IV) chloride (50% aqueous solution,
Carlo Erba) were used as supplied. Corning or Falcon provided
tissue culture materials. Dulbecco’s modified Eagle’s medium
(DMEM) was purchased from Gibco (Gaithersburg, MD, USA);
Tryplet and fetal bovine serum (FBS) were from GibcoBRL (Life
Technologies, Germany).
2.2. Instrumentation and methods
Elemental analysis for carbon and hydrogen was performed
using a Carlo Erba EA1108 analyzer. Sodium determination was
performed using a ROSSs sodium ion selective electrode
(Thermo Scientific 8611BNWP). The vanadium content was
determined by the tungstophosphovanadic method.13 Thermo-
gravimetric analysis (TGA) was performed with a Shimadzu
system (model TG-50), working in an oxygen flow of 50 mL
min1 and at a heating rate of 10 1C min1. Sample quantities
ranged between 10 and 20 mg. UV-vis spectra were recorded on
a Shimadzu 2600/2700 spectrophotometer. Infrared spectra
were measured using the KBr pellet technique with a Bruker
IFS 66 FTIR spectrophotometer from 4000 to 400 cm1. X-band
CW-EPR spectra of a powdered sample were obtained at room
(300 K) and low (120 K) temperatures on a Bruker EMX-Plus
spectrometer, equipped with a rectangular cavity with 100 kHz
field modulation. X-band EPR spectra of frozen solutions were
recorded at 120 K, in DMSO. EPR spectra were simulated with
the EasySpin toolbox based on MATLAB.14 Fluorescence spectra
were obtained with a Shimadzu RF-6000 spectrophotometer
equipped with a pulsed xenon lamp. The molar conductance of
the complex was measured using a Conductivity TDS Probe –
850084, Sper Scientific Direct, using 103 M aqueous solutions.
2.3. Synthesis of Na2[VO(rutin)(OH)2]5H2O
Rutin (1 mmol) was dissolved completely in water (20 mL) by
the addition of a NaOH solution (1 M) until a final pH value of
10. An aqueous solution (10 mL) of VOCl2 (0.5 mmol) was
added with stirring and the pH of the solution decreased to 8.0.

























Fig. 1 Structure of rutin.
2 | New J. Chem., 2019, 00, 111 This journal is c The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2019
Paper NJC
addition of 1 M HCl and it was left stirring for 1 h at room
temperature. Then, isopropyl alcohol was added drop by drop
until a green solid precipitated. The solid was immediately
filtered, washed several times with isopropyl alcohol and air-
dried. Anal. calcd for C27H40O24VNa2: C, 38.5; H, 4.7; V, 6.0; Na,
5.4. Exp.: C, 38.3; H, 4.6; V, 5.9; Na, 5.5. UV-vis data: (DMSO/
H2O): 660 nm (sh), 820 nm. Thermal analysis (TGA) (oxygen
atmosphere, 50 mL min1): in the first step (20–200 1C) five
water molecules are lost (10.3%). The dehydrated product
rendered Na4V2O7 (characterized by infrared spectroscopy)
and the weight of the final residue was 13.5% (calc. 13.3%).
The molar conductance of the complex measured in water, Lm
= 148 (O1 cm2 mol1), suggested the formation of a 1 : 2
electrolyte.15 Elemental analysis and thermal studies allow us
to postulate a L : M stoichiometry of 1 : 1. This result is sup-
ported by spectral determinations (see below).
2.4. Spectrophotometric titrations
In order to establish the stoichiometry of the complex a spectro-
photometric method was applied. A DMSO solution of rutin (8
 103 M) was prepared. The absorption spectra of different
concentration aqueous solutions of VOCl2 in ligand-to-metal
molar ratios from 10 to 0.5 (pH 7) were measured.16 A nitrogen
atmosphere was used during the experiments to prevent oxida-
tion processes.
2.5. Antioxidant properties
The experimental conditions for the antioxidant determina-
tions were set according to previous reports.17 The superoxide
dismutase (SOD) activity was examined indirectly using the
nitroblue tetrazolium (NBT) assay. The indirect determination
of the activity of rutin and the VOrut complex by their ability to
inhibit the reduction of NBT by the superoxide anion (gener-
ated by the phenazine methosulfate (PMS) and reduced nicoti-
namide adenine dinucleotide (NADH) system) was performed.
The capacity to scavenge hydroxyl radicals (generated by the
ascorbate–iron–H2O2 system) has been determined with the
thiobarbituric acid method by the measurement of the extent of
deoxyribose degradation by hydroxyl radicals. The inhibition of
peroxyl radicals was measured by generation of the radicals by
the thermal decomposition of 2,2-azobis(2-amidinopropane)
dihydrochloride (AAPH). The lag phase (delay of pyranine
consumption) was calculated as the time before the consump-
tion of pyranine started (marked reductions in absorbance).
The antiradical activity of the compounds was also measured in
terms of their capacity to scavenge DPPH (1,1-diphenyl-2-
picrylhydrazyl) radicals. Each experiment was performed in
triplicate and at least three independent experiments were
evaluated in each case.
2.6. Biological assays
2.6.1. Cell culture procedure. The A549 human lung cancer
cell line was obtained from ABAC (Argentinean Cell Bank
Association INEVH, Pergamino, Buenos Aires, Argentina) and
the MRC-5 normal embryonic lung cell line was purchased
from IMBICE (Instituto Multidisciplinario de Biologı́a Celular).
The human lung cancer line, A549, was maintained at 37 1C in a
5% carbon dioxide atmosphere using DMEM supplemented
with 100 U mL1 penicillin, 100 mg mL1 streptomycin and 10%
(v/v) fetal bovine serum as the culture medium. Human fetal
lung fibroblast cell line MRC-5 was grown as a monolayer in
DMEM supplemented with 20% fetal bovine serum. When 70–
80% confluence was reached, cells were detached using PBS-
EDTA (11 mM KH2PO4, 26 mM Na2HPO4, 115 mM NaCl, pH 7.4,
1.3 mM EDTA) with 10% TrypLEt (Gibco, Gaithersburg, MD,
USA). Then, the cell suspension was grown in multi-well plates,
6-well plates, 48-well plates, or 96-well plates, depending on the
experiment.
2.6.2. Cell viability assay. Cell viability tests were per-
formed using the MTT assay.18 Cells were treated with com-
pounds at different concentrations, and then they were
assessed in three independent experiments. A549 cells were
seeded at a density of 2  106 per well cultured in 48-well plates
and MRC-5 cells were seeded at a density of 2  104 per well in
96-well plates. After 24 h of incubation, cells were exposed to
different concentrations of VOCl2, rutin and VOrut (0, 2.5, 5, 10,
25, 50, 75, and 100 mM). The dissolution vehicle (DMSO) yielded
a maximum final concentration of 0.5% in the treated well.
After 24 h of incubation at 37 1C, a volume of 250 mL of MTT
solution was added to each well and was incubated for 2 h at
37 1C until a purple-colored formazan product developed.
Formazan was dissolved in acidified isopropanol (cancer cell
line) or DMSO (normal cell line). The absorbance at 560 nm was
measured by UV-vis spectroscopy. Using the same protocol as
described above, the MTT assay was performed in the presence
of NAC (N-acetylcysteine). Cells were pretreated with 5 mM of
NAC for 30 min, followed by treatment with rutin and VOrut at
the same concentrations used before for 24 h.
2.6.3. Intracellular reactive oxygen species (ROS) genera-
tion. Intracellular reactive oxygen species (ROS) generated by
the compounds were evaluated using 20,70-
dichlorodihydrofluorescein diacetate (H2DCFDA, Merck, Darm-
stadt, Germany) by a fluorometric quantitative assay. Briefly,
cells were treated with VOCl2, rutin and VOrut (0–100 mM) for
24 h. Then, the media were removed and cells were incubated
with 250 mL H2DCFDA (10 mM) solution for 1 h at 37 1C in the
dark. The media were removed and the cell monolayers rinsed
with PBS and lysated into 1 mL 0.1% Triton-X100. The cell
extracts were then analyzed for the oxidized product DCF by
fluorescence spectroscopy (lexc, 488 nm; lem, 525 nm). Results
were presented as the percentage of fluorescence intensity
relative to the control measurements  standard error. Results
were corrected for the protein content, which was assessed by
the Bradford method.19 To validate that the ROS in cells were
generated by the compounds, the same assay in the presence of
the antioxidant NAC was performed. Cells were pretreated with
5 mM of NAC for 30 min, followed by treatment with rutin and
VOrut at different concentrations for 24 h.20
2.6.4. Estimation of the cell glutathione (GSH) and oxi-
dized glutathione (GSSG) content.. The determination of the
reduced (GSH) and oxidized glutathione (GSSG) content in
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and Hilf’s method.21 Standard curves of GSH and GSSG (0.01–
1.0 mg mL1) were processed in parallel. Briefly, for GSH
determinations 100 mL aliquots were mixed with 1.8 mL of ice
cold phosphate buffer (Na2HPO4 0.1 M–EDTA 0.005 M, pH 8)
and 100 mL o-phthaldialdehyde (OPT) (0.1% in methanol). For
the determination of GSSG, 100 mL aliquots were mixed with 1.8
mL NaOH 0.1 M and OPT but previously and to avoid GSH
oxidation the cellular extracts for GSSG determination were
incubated with 0.04 M of N-ethyl-maleimide (NEM). The pro-
tein content in each cellular extract was quantified using the
Bradford method.19 The fluorescence spectra were recorded at
350 nm excitation and 420 nm emission wavelengths. The
concentrations in mg GSH/mg protein were calculated from
the respective calibration curves. The ratio GSH/GSSG was
expressed as a percentage of the control for all the experimental
conditions.
2.7. Bovine serum albumin interactions
To 4800 mL of Tris–HCl (0.1 M, pH 7.4), 10 mL of an aqueous
solution of BSA at a final concentration of 6 mM and 10 mL of a
DMSO solution of rutin or an aqueous solution of VOrut were
added and left to rest for 1 h to ensure the formation of
homogeneous solutions. The final concentrations of the com-
pounds ranged between 5 and 100 mM, and buffer was used for
the control. The fluorescence intensity was measured on a
luminescence spectrometer (excitation at 280 nm and emission
at 350 nm) at 298, 303 and 310 K. For each sample, three
independent replicates were performed.
2.8. Statistical analysis
Data are expressed as the mean  standard error (SE). The
analysis of variance (one way ANOVA) was applied by the test of
least significant difference (Fisher) to compare the means of
multiple groups of measured data. Significance was defined as
p o 0.05.
3. Results and discussion
3.1. Characterization of the VOrut complex
3.1.1. FTIR spectroscopy. The assignments of the main
bands of the infrared spectra of the ligand and the complex
were performed based on previous studies on the flavonoid, its
alkali metal salts,22 and the Zn/rutin23 and V(IV)O/rutin
complexes.11
In previous reports, the FTIR spectrum of rutin showed the
stretching vibration of the carbonyl group at 1654 cm1 and
this band shifted to lower wavenumbers (1621 cm1 and 1627
cm1) upon coordination to V(IV)O and Zn(II), respectively.
These shifts were indicative of the coordination of the carbonyl
group to the metal centers, due to the decrease of both the
bond strength and the charge density of the CQO group. In
VOrut the CQO stretching band of rutin did not shift upon
complexation, indicating that this group did not participate in
metal bonding (Table S1, ESI†). The position of the VQO
stretching band is another indication of the coordination mode
of the metal to the flavonoid. In the reported complexes with
rutin this band was located at 983–972 cm1 in accordance with
chelation through the CQO and C–O moieties at rings A and C,
generating a delocalized p system that allows the resonance
with the VQO bond, maintaining the double bond character
between vanadium and oxygen atoms. In the present complex
this band shifted to low frequencies 920 cm1 typical of
catechol-like coordination involving cis-deprotonated OH
groups at ring B. In this type of coordination the inductive
effect of the negative charges on the aryloxy groups produces a
lengthening of the VQO bond and a decrease in the vibrational
wavenumber. The stretching band vibrations assigned to the
aromatic ring B at 1505 cm1 shifted to 1485 cm1, showing
interaction of the metal center with the 30 and 40-deprotonated
OH groups of rutin. Bands related to CO stretching and COH
bending at 1013 cm1 and 1296 cm1 diminished in their
intensities or shifted, suggesting deprotonation and/or coordi-
nation to the VQO cation. The FTIR data suggest that the
favored metal coordination occurs through the ortho-hydroxyl
groups in the B ring rather than the 5-hydroxypyran-4-one
moiety.
3.1.2. Powder EPR spectrum. The powder EPR spectra
obtained at low temperature (Fig. S1, ESI†) and at room tem-
perature (not shown) were similar. The EPR spectrum of VOrut
microcrystalline powder shows the typical eight line hyperfine
splitting pattern of the 51V nucleus (I = 7/2), indicating absent (or
almost negligible) magnetic interactions between paramagnetic
V(IV)O2+ ions in the solid complex, which would collapse the
hyperfine interaction. The EPR spectrum is also indicative of the
presence of only one mononuclear oxidovanadium(IV) species in
the solid complex. The experimental spectrum could be well
simulated assuming g-and A-matrices with nearly axial symmetry
and the simulation gave: g1 = 1.9869, g2 = 1.9763, g3 = 1.9477; A1 =
28.7 104 cm1, A2 = 51.7 104 cm1; A3 = 158.9 104 cm1.
Considering the additivity relationship for VO-systems, regarding
the magnitude of AII
24 the nature of the equatorial ligands can be
suggested. The hyperfine component AII for different ligand
composition has been calculated as: Az =
P
niAz,i, ni being the
number of equatorial ligands of type i and Az,i the contribution to
the parallel hyperfine coupling from each of them. Considering
the stoichiometry determined for the complex (see above), the
contributions to the parallel hyperfine coupling constant were
calculated taking into account two hydroxyl groups and one
flavonoid molecule around the metal center (2OH) = 2  38.7
 104 cm1 and 2ArO (catechol-like from one rutin molecule) =
38.6  104 cm1, = 154.6  104 cm1.25 For the ligands
containing a catecholic donor set, the formation of square
pyramidal complexes with (O, O) catechol-like coordination
forming five-membered chelate rings is preferred at physiological
pH values. The values of the hyperfine coupling constants were
similar to those measured for V(IV)O–flavonoid complexes bear-
ing catechol-like coordination such as 7,8-dihydroxyflavone, bai-
calein, fisetin, and quercetin and, in particular, to the values
previously obtained for the oxidovanadium(IV)–rutin system in
solution at pH 4 6.12 However, in acidic pH ranges, the reported
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oxidovanadium(IV) and rutin, in DMSO/water 1 : 1, showed
acetylacetonate-like coordination (gz 1.941, Az 174.9  104
cm1). From the EPR parameters we conclude that the conforma-
tion of the complex would correspond to a binding mode of
2(OH, ArO). Hence, the simulation predicted that the observed
signal originating from a vanadium chromophore is consistent
with catechol-like coordination of the oxidovanadium(IV) ion, in
good agreement with the FTIR spectrum.
3.2. Solution studies
3.2.1. UV-vis spectroscopy. The electronic UV-vis spectrum
of rutin has previously been described.22,23,26 Rutin exhibited
two bands at 258 nm (band II, benzoyl ring A) and 352 nm
(band I, cinnamoyl associated with the conjugated system
between ring B and the carbonyl of ring C) due to p–p*
transitions. We obtained the same results in water solution
but this spectral pattern changed with the pH, according to the
deprotonation of the different acidic groups, depending on
their pK values. The dissociation of rutin proceeds in the
following order: 7-OH, 30-OH, 5-OH, 40-OH.27 Then, the spectral
pattern changed sequentially with the change of pH (Fig. S2A,
ESI†): the band at 258 nm shifted at pH values higher than 3 to
265 nm (pH 6) and to 271 nm (pH 8) and the intensities
increased while band I shifted to 390 nm (pH 6) and 399 nm
(pH 8 and higher).
It is known that metal ions compete with protons for ligand
binding in aqueous solution, and hence upon coordination
with the acidic metal cation the pKa constants of the ligand
changed. As an example, the pKa value of water decreases when
it coordinates to Zn from 15.74 to 9.0. In particular, when the
V(IV)O cation coordinates to the deprotonated 30-OH group, the
pKa value of the 40-OH group in the cis position lowers and
makes this position a better donor atom, generating the ortho-
dihydroxyl (catechol) environment. The electronic spectral pat-
tern for an aqueous mixture of 5  105 M rutin and 2.5  105
M oxidovanadium(IV) cations at different pH values (Fig. S2B,
ESI†) showed that the band at 258 nm shifted to 265 nm (pH 4)
and 275 nm (pH 5), both with similar intensities, and 270 nm
(pH 8) with high intensity. Band I shifted from 350 nm to
412 nm (pH 5). At a pH value ca. 4, an equilibrium between two
species can be observed (bands at 360 nm and 402 nm). At pH
values of 5 and 8, the new band I remained at 414 nm. The red
shift of band I (from 390 in rutin to 412 nm in the complex) is
indicative of complex formation. It can even be seen that
complex formation takes place at pH values lower than the
pH of ligand deprotonation, as expected.
The visible range of the electronic spectrum displayed a
band at 820 nm suggesting formation of the mono-
catecholate28 and resembles those of V(IV)O flavonoids with
catechol like coordination.7,9 To determine the stoichiometry of
the VOrut complex in solution, a spectrophotometric titration
was performed in the visible part of the electronic spectrum of a
DMSO/aqueous solution of the complex, at the maximum of the
d - d transition band. The spectral patterns of different
ligand-to-metal (8  103 M) DMSO rutin solutions, pH 7,
under a nitrogen atmosphere (Fig. S2C, ESI†) showed that the
band at 820 nm increased its intensity upon addition of
different quantities of aqueous solutions of V(IV)O. The molar
ratio plot indicated the formation of a 1 : 1 rutin–VO complex
(Fig. S2C, ESI,† inset).
3.2.2. EPR spectrum in solution. The EPR spectrum
obtained in a frozen solution at 120 K in DMSO (Fig. S3, ESI†)
shows the typical eight-line pattern spectrum for V(IV)O2+
systems. The solution experimental spectrum can be well
simulated assuming g-and A-matrices with nearly axial symme-
try. This signal indicated the formation of single mononuclear
species after the dissolution process (Az = 157.7  104 cm1).
The EPR parameters obtained by simulation predicted, in a
similar way as for the powder EPR spectrum, that the observed
signal is consistent with catechol-like coordination of the
oxidovanadium(IV) ion.
3.2.3. Stability studies. The stability of the complex in
aqueous solution was followed by UV-vis and EPR spectro-
scopies and conductimetric studies. The spectral changes in
the electronic spectra of 6.7 mM (DMSO/H2O) of VOrut during
60 min were negligible (data not shown). The conductimetric
measurements were performed with 25 mL of an aqueous 1 
103 M solution of the complex, in duplicate. The values ranged
from 148 to 149 (O1 cm2 mol1), 60 min. These values indicate
that during the manipulation time for biological studies (15
min) the complex remained without decomposition. The stabi-
lity of a DMSO solution of the complex was measured using
EPR spectroscopy (Fig. S4, ESI†). Although the measurements
were performed at 120 K (where the thermal decomposition
should occur more slowly) no appreciable changes in the
spectral pattern were observed, indicating that the compound
remained stable for at least 60 min.





2 showed the VQO vibrational stretching band at
920 cm1, this band is absent in the tris-catechol because the
chelating ability of catechol produced the displacement of the
oxidovanadium(IV) oxygen. The EPR parameters were determined
as Az 170  104 cm1, 154  104 cm1 and 14  104 cm1,
respectively.30 The value of Az 157.7  104 cm1 for
Na2[VO(rut)(OH)2]5H2O is indicative of the presence of two rutin
ligands or one rutin and two hydroxo anions (according to the
additivity rule), discarding the tris-catechol complex formation,
probably because of steric hindrance. Furthermore, the electro-
nic spectra of the three catechol based oxidovanadium(IV) com-
plexes in aqueous solutions showed bands at 750 nm (33),
550 nm (28) (H2O); 656 nm (69), 540 nm (38) (H2O); and
552 nm (9200), 650 nm, sh (8200) (CH3CN), respectively. The
UV-visible data for Na2[VO(rut)(OH)2]5H2O (DMSO/H2O),
820 nm (42), 660 nm, sh (29), resembles the spectral pattern of
the mono-catechol complex. Altogether the experimental mea-
surements in the solid state and in solution point to a M : L 1 : 1
stoichiometry in the complex.
3.3. Antioxidant activity
The radical scavenging power of rutin and VOrut has been
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peroxyl and hydroxyl radicals) and DPPH radical (Fig. S5,
ESI†).
The flavonoid rutin is not able to cause dismutation of the
superoxide radicals. This behavior has been slightly improved
by complexation, though its activity is low (IC50 = 356 mM) (Fig.
S5A, ESI†). A similar antioxidant improvement has been found
for the Znrut complex with respect to rutin.23 The superoxide
radical scavenging power of rutin was reported to be somehow
higher, but this effect may be due to the different experimental
design.31 The peroxyl radicals were measured by the thermal
decomposition of AAPH following the decay of the spectro-
metric probe, pyranine. The lag phase (the capacity of a
compound to scavenge peroxyl radicals) was calculated based
on the consumption time of peroxyl radicals by the com-
pounds, prior to the beginning of pyranine consumption. The
scavenging power of rutin against peroxyl radicals (Fig. S5B,
ESI†) was higher than the effects of the complex and the
antioxidant, a vitamin E analog, trolox. The ligand displayed
weak antioxidant power against hydroxyl radicals. This beha-
vior has been improved by complexation (Fig. S5C, ESI†).
Similar results for rutin were previously obtained. Rutin was a
better scavenger of DPPH radicals than the complex (IC50 = 32
mM vs. 44 mM, Fig. S5D, ESI†). The radical scavenging activity of
rutin against DPPH has been reported by several authors. The
different data show that 10 mM, 30.4 mM and 82 mM rutin
inhibited 61.7%,22 45%,24 and 90.4%.,31 respectively. Other
reports showed that the antioxidant action of the rutin complex
of Ni(II) was slightly stronger than that of free rutin26 with IC50 =
12.6 mM for the complex.32
Interestingly, the antioxidant behavior against DPPH was
reported for the complex of V(IV)O with rutin11 and the authors
found that there was an improvement of the ligand behavior by
complexation and the same trend was reported for the Zn(II)
and Ni(II) complexes. In all these complexes the coordination
environment (CQO and O) is an acetylacetonate-type one. As
it has been mentioned in the Introduction, we found that when
the metal center coordinates to the flavonoid through the
carbonyl and one deprotonated adjacent OH group, the reso-
nance established between rings C and/or A allows the stabili-
zation of the flavonoid radical. In these cases, the systems have
better antioxidant power. On the contrary, when these groups
were not involved in metal coordination, the antioxidant power
of the flavonoid has not totally been improved by metal
interaction, like in the present case with catechol-type coordi-
nation of V(IV)O with rutin.
3.4. Human lung cancer cells
3.4.1. Cell viability assay (MTT method). The effects of
rutin, VOrut and the V(IV)O cation were investigated by the
conventional MTT assay and the IC50 value for the complex (the
concentration that inhibits 50% cell viability) was determined
using the SigmaPlot software. Ligand solutions were prepared
in DMSO (0.5%)/buffer and DMSO (0.5%) was used as a solvent
control, and did not show any significant toxicity. It has been
reported that rutin produced a reduction in tumor size (human
leukemia HL-60 cells implanted in a murine model), and
inhibited the growth of neuroblastoma LAN-5 cells, and color-
ectal (SW480), cervical (HeLa), breast (MDA-MB231) and ovar-
ian (OVCA433) cancer cell lines, the IC50 values being higher
than 100 mM. After 72 h incubation rutin kills cancer cells at
relatively high concentrations (IC50 = 388 mM, HT29, and 710
mM, Caco-2 colon cancer cell lines and 560 mM, the A549 human
lung cancer cell line).3 Besides, rutin did not display toxic
effects on nontumorigenic HaCaT cells.33 From our experi-
mental data (Fig. 2A) it can be seen that rutin did not show
anticancer activity against the human lung A549 cancer cell line
at concentrations up to 100 mM, and that V(IV)O cations
inhibited only 16% cell viability. Aqueous solutions of VOrut
significantly inhibited the growth of lung cancer cells in a dose


























Fig. 2 Effect of rutin, VOrut and oxidovanadium(IV) cations on (A) cancer cell line A549 viability inhibition and (B) effect of rutin and VOrut on MRC-5 cell
line viability. The cell lines were treated with various concentrations of the compounds for 24 h. The results are expressed as the percentage of the
control level and represent the mean the standard error of the mean (SEM) from three separate experiments. * significant values in comparison with the
control level (p o 0.05).
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The deleterious effect in cancer cells is selective (Fig. 2B). In
the normal human cell culture line of fibroblasts derived from
lung tissue, MRC-5, rutin and VOrutin did not inhibit cell
viability at the tested concentrations during 24 h (incubation
time). In the previous acute study of the VOrut complex with
acetylacetonate coordination a LC50 value of 120 mg kg
1 body
weight in fasted balb/c mice has been determined, but these
toxic effects were transient.11
3.4.2. Intracellular ROS generation. It is known that cancer
cells have higher levels of ROS than normal cells, and that ROS
are responsible for the cancer phenotype.34 The antioxidant
compounds flavonoids can also act as pro-oxidant agents in
cancer cells through the interaction of the flavonoid radicals
(generated after electron or H donation) with oxygen in the
presence of transition metals. Flavonoid radicals therefore
generate quinone while molecular oxygen generated superoxide
radicals. These radicals are very reactive and can harm essential
macromolecules such as proteins or DNA. Flavonoid metal
complexes could improve the anti-cancer effects of flavonoids
via the pro-oxidant behavior that is manifested mainly in
cancer cells. To investigate the behavior of rutin and VOrut
the levels of intracellular ROS were determined by DCFH-DA
assay. This probe is useful for detecting intracellular H2O2 and
oxidative stress. From Fig. 3 it can be seen that VOrut generated
intracellular ROS. However, no ROS production in treated cells
was determined for both rutin and V(IV)O cations. Moreover, it
hasQ4 been reported that 100 mM rutin decreased superoxide
production by 57% in the A549 cell line, in comparison with
untreated cells, using lucigenin chemiluminescence for the
detection of superoxide ions.3
The increase in the amount of intracellular ROS produced by
the complex generated a cancer cell killing effect and hence we
assumed that oxidative stress may play a key role in its toxic
effect. To confirm this assumption we studied the effect of N-
acetyl-cysteine (NAC) on the ROS levels (Fig. 3A). The
pretreatment of the cell line with 5 mM NAC and VOrut
suppressed the generation of intracellular ROS. The complex
elevates the amount of intracellular ROS allowing cancer cells
to be selectively killed. When the generation of cellular ROS was
suppressed, the cell viability was recovered (Fig. 3B). Then, we
can demonstrate the involvement of oxidative stress as one of
the mechanisms of lung cancer cell death.
3.4.3. Cellular glutathione (GSH) depletion. GSH prevents
damage caused by ROS to important cellular components. One
of the indices of oxidative stress is the depletion of the non-
enzymatic antioxidant glutathione (GSH), producing oxidized
glutathione (GSSG) that is toxic to the cell. To support the
oxidative stress mechanism of action, the concentrations of
GSH and GSSG were measured in A549 cells pretreated with
different concentrations of rutin and VOrut and the GSH/GSGG
ratio was calculated. As expected, rutin did not alter the GSH
and GSSG levels (Fig. 4). The metal complex decreases both
GSH and GSH/GSSG, showing that GSH is oxidized to GSSG
(decreasing the endogenous antioxidant concentration in the
cell and accumulating its oxidation product). The production of
cellular ROS, the disruption of one of the natural antioxidant
systems (GSH/GSSG) and the absence of toxicity when ROS
generation was suppressed allow us to suggest an oxidative
stress mediated mechanism of action for the cancer cell killing
effect of the complex.
3.4.4. Morphological changes. The morphological changes
of the A549 cells (5 and 100 mM VOrut incubation, 24 h) are
shown in Fig. 5. The toxicity of 100 mM VOrut is determined by
the increase of cytoplasm condensation and the presence of
pycnotic nuclei. These observations agree with the results
obtained in the cell viability studies.
3.5. Bovine serum albumin (BSA) interactions
Serum albumin is the most abundant plasma carrier protein in

























Fig. 3 (A) Effect of rutin, VOrut and oxidovanadium(IV) cations on H2DCFDA oxidation to DCF (A549 cells were incubated at 37 1C in the presence of 10
mM H2DCFDA) and the effect of N-acetyl-L-cysteine (NAC, 5 mM) on ROS production induced by VOrut. (B) Inhibitory effects of VOrut on A549 cell
viability in the presence of N-acetyl-L-cysteine (NAC, 5 mM). The cell line was treated with various concentrations of the complex at 37 1C for 24 h. The
values are expressed as a percentage of the control level and represent the mean  SEM. * significant values in comparison with the control level (p o
0.05). # significant differences at the same concentration between rutin and VOrut, p o 0.05 (A) and # significant differences at the same concentration
between VOrut with NAC and VOrut, p o 0.05 (B).
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the bloodstream. Bovine serum albumin is a serum protein
from cows, chemically similar to human serum albumin, but
with low cost. Fluorescence quenching measurements have been
widely used to study the interactions of compounds with this
protein.35 The intrinsic fluorescence of BSA when excited at
280 nm is due to excitation mainly of the tryptophan residues.
The emission spectra of BSA decrease in intensity with an
increasing concentration of rutin and its complex (Fig. S6, ESI†).
To determine the quenching constants the fluorescence data
have been analyzed with the Stern–Volmer equation at different
temperatures:35
F0/F = 1 + Kqt0[Q] = 1 + KSV[Q] (1)
where F0 and F are the fluorescence intensities in the absence
and presence of the quencher, respectively; Kq is the bimole-
cular quenching constant; t0 is the lifetime of the fluorophore
in the absence of the quencher; [Q] is the concentration of the
quencher and Ksv is the Stern–Volmer quenching constant,
which can be obtained from the slope of eqn (1). The Stern–
Volmer plots are shown in Fig. S7 (ESI†).
The average values of Ksv were obtained from the slopes of
the straight lines by linear regression treatment (Table 1). The
quenching constants were calculated considering a fluores-
cence lifetime t0 of BSA of 1.0  108 s. Taking into account
that the scattering collision (dynamic) quenching of various
quenchers with biopolymers is 2.0  1010 L mol1 s1, the high
Kq values obtained in this study indicated static quenching
between BSA and the compounds due to their binding and
complex formation between the protein and quencher.35
For static quenching, from the plot of log [(F0  F)/F] vs. log
[Q], the binding constants Ka and the number of binding sites n
were determined (Fig. S8, ESI† and Table 1), according to the
following equation:
log[(F0  F)/F] = log Ka + n log[Q] (2)
Only one binding site for the bonding between BSA and the

























Fig. 4 Effect of rutin, VOrut and oxidovanadium(IV) cations on GSH cellular levels and the GSH/GSSG ratio in A549 cells. Results are expressed as the
mean  SEM of three independent experiments, * significant differences in comparison with the control level (p o 0.05).
Fig. 5 Effect on the cell morphology of the treatment of the A549 cell line with VOrut. Cells were incubated for 24 h without the drug (control), and with
5 and 100 mM VOrut.
Table 1 Stern–Volmer constant (Ksv), quenching rate constant (Kq), bind-
ing constant (Ka) and n binding sites for the interaction of rutin and VOrut











Rutin 298 5.99  0.21 5.99  0.21 19.8  0.52 1.13  0.11
303 4.95  0.21 4.95  0.21 10.2  0.45 1.08  0.10
310 4.85  0.15 4.85  0.15 9.75  0.20 1.07  0.04
VOrut 298 6.66  0.24 6.66  0.24 60.4  0.21 1.22  0.05
303 6.28  0.41 6.28  0.41 52.1  0.51 1.21  0.12
310 6.17  0.24 6.17  0.24 43.1  0.24 1.18  0.06
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with temperature according to a decrease in stability of the BSA-
compound binding.
The value of Ka will directly correlate with the transport,
disposition, and in vivo efficacy of a compound. The magnitude of
our experimental values (ca. 105 M1) suggested moderate affinity
of the compounds for BSA and that they could be stored and
removed by BSA. Moreover, and despite the different procedures
used, our data for KSV and Ka for rutin were similar to those
previously reported. Total quenching using tryptophan fluorescence
was reported for rutin–BSA at a molar ratio of 25/1 (KSV = 19.2 104
M1), the binding affinity being lower than for its aglycon, querce-
tin. The rutinose disaccharide makes rutin less hydrophobic and
more bulky, producing steric hindrance for the hydrophobic pocket
of Trp 212.36 Moreover, a static quenching process through the Trp
212 residue was reported for the interaction rutin–BSA (KSV = 3.2 
104 M1, Ka = 4.40  105 M1, binding sites = 1.40).37 The complex
interacted more strongly with BSA than rutin. The interaction of
rutin and the V(IV)O complexes (acetylacetonate like coordination)
with BSA has previously been reported10 and the increased fluores-
cence intensities produced by the complexes were ascribed to a
higher rigidity of the ligand in the complex.
Basically, four main types of forces may be involved in
protein–compound interactions: hydrogen bonds and electro-
static, van der Waals or hydrophobic forces, and they were
evaluated through the thermodynamic parameters (the van’t
Hoff equation, eqn (3)):
ln Ka = DH/RT + DS/R (3)
where Ka is analogous to the associative binding constants at
the corresponding experimental temperature T and R is the gas
constant. The free energy change (DG) can be estimated from
the following relationship (4):
DG = DH  TDS (4)
The thermodynamic parameters are summarized in Table 2.
The negative sign for the free energy (DG) shows that the
binding processes are spontaneous. The negative value of DH for
both compounds suggested that the binding to BSA is an
exothermic process and then the association constant decreases
with increasing temperature. A negative value of DS suggests that
the binding process is predominately enthalpy driven by means
of hydrogen bonding and van der Waals force interactions while
a positive DS change occurs when the water molecules are
arranged around the ligand and the protein acquires a more
random configuration as a result of hydrophobic interactions.
From Table 2 it can be seen that van der Waals forces and
hydrogen bonding play a significant role in the binding of rutin
to BSA. The negative enthalpy (DH) and positive entropy (DS)
values of the interaction of VOrut and BSA indicate that specific
electrostatic interactions played a major role.38 Taking into
account the resonant structures of rutin and tryptophan and
tyrosine, it is reasonable to expect p–p interactions between the
aromatic rings of BSA and the compounds. On the other hand,
the anionic nature of the complex [VO(rutin)(OH)2]
2 allows
electrostatic interactions with BSA, and stronger binding con-
stants for the BSA–VOrut system.
4. Discussion
Two solid complexes formed between the oxidovanadium(IV)
cation and rutin have previously been synthesized and char-
acterized as [VO(rutin)(H2O)2]2(SO4)4H2O and [VO(Rut)2]
4H2O.
10,11 In these complexes an acetylacetonate-type coordi-
nation sphere around the metal center was found. Attempts to
obtain the same complexes gave the solid Na2[VO(rut)(OH)2]
5H2O complex (see Fig. 6). Elemental analysis, thermogravi-
metric determinations and FTIR and EPR spectroscopies allow
the characterization of the solid compound.
The complex displayed catechol-like coordination in which
deprotonated oxygen atoms in 30- and 40-positions are bonded
to the metal center. The VOrut complex improved the antiox-
idant potency of the ligand only against superoxide and hydro-
xyl radicals but not against peroxyl and DPPH radicals. This
behavior is consistent with our previous findings: the better
antioxidant VOflavonoid complexes are those in which the
carbonyl group is involved in the metal interaction, bearing
maltol- or acetylacetonate-type coordination. At this point it
should be noted that the antioxidant effect of the [VO(rut)2]
4H2O complex in which the CQO and deprotonated 5-OH
groups are involved in metal coordination was reported to have
greater antioxidant power against DPPH than the ligand,
because of the generated electronic delocalization that stabi-


























Table 2 Thermodynamic parameters for the interactions between rutin
and VOrut and BSA
DH (kJ mol1) DS (J mol1) DG (kJ mol1)
Rutin 42.6 42.7 29.9 (298 K)
29.7 (303 K)
29.4 (310 K)
VOrut 21.6 38.2 33.0 (298 K)
33.2 (303 K)
33.4 (310 K) Fig. 6 Schematic representation of Na2[VO(rut)(OH)2]5H2O.
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Furthermore, the biological properties of different com-
plexes of V(IV)O and flavonoids are highly dependent on the
substituents of the flavonoids. It is known that during the
transition from normal tissue to carcinoma, cells produce high
levels of ROS due to their metabolic aberrations, and because
cancer cells are more vulnerable to ROS than normal cells, ROS
generating compounds can kill cancer cells selectively. We have
previously determined in the human lung cancer A549 cell line
that some complexes with glycosylated flavonoids produced a
higher improvement in the generation of cellular ROS with
respect to the ligands and then the cells were more vulnerable
to damage by those ROS insults (Table 3).
As can be seem from Table 3, complexation of the non-
glycosylated flavonoids apigenin and luteolin did not improve
the anticancer effects of the flavonoids.7,17 However, when
baicalin and diosmin coordinated to the oxidovanadium(IV)
cation the production of cellular ROS is increased 1.8 and 1.4
times, respectively.8,9 The anticancer effects of both complexes
associated with this oxidative stress are increased 1.2 times for
BaicalinVO and 1.5 times for DiosminVO.
To confirm these findings and determine a structure–activity
relationship for the anticancer effects of these complexes, we
have selected herein the glycosylated flavonoid rutin. The
complex displayed the ability to generate ROS and deplete
cellular antioxidants: cellular ROS increased 1.7 times upon
complexation and the anticancer effect of VOrut was 2 times
higher than the effect of the glycosylated flavonoid rutin. Then, a
relationship between the structure of the VOflavonid complexes
and their activities could be determined: the V(IV)O complexes of
glycosylated flavonoids show a better improvement of the anti-
cancer action. These findings were also discussed for glycosidic
antibiotics such as daunomycin and adriamycin in which the
glycosidic residues are crucial to their activity. The role of the
glycosidic residue in the biological activity of glycosidic antibio-
tics has been explained by the intercalation of the aglycone with
DNA, the aminosugar being the anchoring unit which fills the
minor groove, displacing water and ions from the groove. Hence,
the aminosugar may interact with polymerases, preventing or
retarding the action of these enzymes.39 Therefore, and in
addition to ROS production, the higher rigidity of the ligand
rutin in the complex, previously described by the increased
fluorescence intensities for the complexes,10 may generate better
intercalation of the complexed ligand with DNA, the sugar being
the anchoring unit which fills the minor groove and is able to
interact with polymerases.
The binding constants obtained for the ligand and the
complex with BSA are in the suitable range of binding by which
the carrier can be useful for the transportation of both com-
pounds and also their release into solution and cells.
5. Conclusion
In summary, we present more evidence that the
oxidovanadium(IV) complexes with glycosylated flavonoids
improved the anticancer action of the ligand in lung cancer
A549 cell lines. The complex VOrut bearing catechol-like coor-
dination displayed stronger anticancer activity and cellular ROS
generation than rutin. It inhibited cellular growth, and led to a
substantial increase in ROS formation and to a decrease of the
GSH/GSSG ratio. Furthermore, upon addition of NAC the
anticancer effect has been reverted. These results evidenced
that the complex induce cell death via an oxidative stress
mechanism, acting as a pro-oxidant agent in cancer cells
despite its antioxidant behavior displayed in the in vitro experi-
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Table 3 Cell viability and cellular ROS generation for 100 mM concentrations of the different compounds incubated for 24 h in the A549 cancer cell line.
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